| 0 (0%) | 02-21 12:57 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 1.72 | 1-year : | 2.19 |
| Resists | First : | 1.47 | Second : | 1.87 |
| Pivot price | 1.11  |
|||
| Supports | First : | 0.83 | Second : | 0.69 |
| MAs | MA(5) : | 1.28 |
MA(20) : | 1.09 |
| MA(100) : | 1.45 |
MA(250) : | 1.78 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 26.5 |
D(3) : | 41.2 |
| RSI | RSI(14): 45.9 |
|||
| 52-week | High : | 4.19 | Low : | 0.83 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ PHIO ] has closed above bottom band by 40.7%. Bollinger Bands are 91.8% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 4 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 1.16 - 1.17 | 1.17 - 1.18 |
| Low: | 1 - 1.01 | 1.01 - 1.02 |
| Close: | 1.02 - 1.03 | 1.03 - 1.04 |
Fri, 20 Feb 2026
QuantumXC Simplifies Quantum-Safe Encryption with Containerized Phio TX-EM Router Integration - Quantum Zeitgeist
Thu, 19 Feb 2026
Phio reshapes leadership as PH-762 cancer drug nears key tests - Stock Titan
Thu, 19 Feb 2026
Phio Pharmaceuticals Aligns Leadership Team to Support Next Stage Development of PH-762 and Advancement of PH-894 - TMX Newsfile
Wed, 18 Feb 2026
Phio Pharmaceuticals Boosts CEO Severance and Incentive Compensation - TipRanks
Wed, 18 Feb 2026
$PHIO stock is down 23% today. Here's what we see in our data. - Quiver Quantitative
Tue, 10 Feb 2026
Phio Pharmaceuticals Corp Announces Positive Phase 1b Trial Results for PH-762 - TradingView
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 11 (M) |
| Shares Float | 11 (M) |
| Held by Insiders | 4.2 (%) |
| Held by Institutions | 7.3 (%) |
| Shares Short | 475 (K) |
| Shares Short P.Month | 202 (K) |
| EPS | -2.14 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 1.7 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -60.2 % |
| Return on Equity (ttm) | -107.6 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | -0.39 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -0.78 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -7 (M) |
| Levered Free Cash Flow | -5 (M) |
| PE Ratio | -0.49 |
| PEG Ratio | 0 |
| Price to Book value | 0.6 |
| Price to Sales | 0 |
| Price to Cash Flow | -1.53 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|